Literature DB >> 1536793

On the limitations of the psoriasis area and severity index (PASI)

P C van de Kerkhof.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1536793     DOI： 10.1111/j.1365-2133.1992.tb07827.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

Review 1.  Systematic review of cost-effectiveness analyses of treatments for psoriasis.

Authors:  Wei Zhang; Nazrul Islam; Canice Ma; Aslam H Anis
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

2.  Reduction of Inter-Rater and Intra-Rater Variability in Psoriasis Area and Severity Index Assessment by Photographic Training.

Authors:  Sang Woong Youn; Chong Won Choi; Bo Ri Kim; Je Byeong Chae
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

3.  Exploration of the Product of the 5-Point Investigator's Global Assessment and Body Surface Area (IGA × BSA) as a Practical Minimal Disease Activity Goal in Patients with Moderate-to-Severe Psoriasis.

Authors:  Alice B Gottlieb; Rebecca Germino; Vivian Herrera; Xiangyi Meng; Joseph F Merola
Journal:  Dermatology       Date:  2019-05-29       Impact factor: 5.366

4.  Add-on effect of PSORI-CM01 to topical calcipotriol for moderate psoriasis vulgaris: A multi-center, randomized, double-blind pilot study.

Authors:  Shefton Parker; Anthony Lin Zhang; Claire Shuiqing Zhang; Greg Goodman; Zehuai Wen; Yuhong Yan; Danni Yao; Huimei Wu; Hao Deng; Chuanjian Lu; Charlie Changli Xue
Journal:  Clin Transl Med       Date:  2021-01

5.  Circulating adiponectin levels in Indian patients with psoriasis and its relation to metabolic syndrome.

Authors:  Shraddha Madanagobalane; Venkatswami Sandhya; Sankarasubramanian Anandan; Krishna G Seshadri
Journal:  Indian J Endocrinol Metab       Date:  2014-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.